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Abstract:  
Retinal vessels are directly accessible to clinical observation. This has numerous potential 
interests for medical investigations. Using the Retinal Vessel Analyzer, a dedicated eye 
fundus camera enabling dynamic, video-rate recording of micrometric changes of the 
diameter of retinal vessels, we developed a semi-automated computer tool that extracts the 
heart beat rate and pulse amplitude values from the records. The extracted data enabled us to 
show that there is a decreasing relationship between heart beat rate and pulse amplitude of 
arteries and veins. Such an approach will facilitate the modeling of hemodynamic interactions 
in small vessels.  
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1 Introduction 
The retinal vascular network is the only microcirculatory network that can be thoroughly 
observed in a noninvasive fashion. In most subjects, spontaneous pulsation of retinal arteries 
and/or veins can be detected on fundus examination. These pulsations result from the cyclic 
nature of cardiac output which propagates a pulse wave throughout the vascular tree at each 
systole. Passive vessel pulse associates longitudinal pulse (i.e. variation in length and/or 
tortuosity, (1)) and transversal pulse (i.e. variations in diameter). In retinal vessels, it is likely 
that the systolodiastolic variations of vessel diameter, termed here pulse amplitude (PA), 
result from the net effect of the interaction of variations of transmural pressure (which is 
proportional to the difference between intraluminal and intravitreal pressure) and retinal 
vessels compliance. Hence, it can be hypothesized that measuring the PA is likely to provide 
potential cues about several parameters related to ocular or general circulation, in particular 
regarding vessel compliance and intraluminal pressure. For instance, arteriolosclerosis 
increases the stiffness of arterioles; the latter should shift to the right the pressure-diameter 
relationship and the question remains opened, whether the macrocirculation compensates or 
not such changes.. Also, it is conceivable that luminal pressure modulates the PA. This may 
explain why venous pulse is not detectable in most patients with increased intracranial 
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pressure (2). Yet, the quantitative relationship between the PA and hemodynamic factors 
remains to be investigated. 
Initial studies of retinal vessel pulse used fundus photographs synchronized with the 
electrocardiogram and manual determination of vessel diameter (3). Recently, an automated, 
on-line approach of the PA of retinal vessel was made possible through computerized analysis 
of videorecordings of the fundus (4). The Retinal Vessel Analyzer® (RVA; Imedos, Jena, 
Germany) indeed records the temporal evolution of the vascular segment diameter. In order to 
perform a quantitative study of the PA, we have developed a computer tool that extracts the 
PA and heart beat rate (HBR) sequences from the RVA signal.  
Several studies used the RVA signal to investigate the vessel stiffness and the HBR. In (5), 
the authors suggest stimuli to apply to the patient eyes during the measurements, like flicker 
stimulation or systemic hyperoxia, with the goal to analyze their influence on the resulting 
signals. Another approach is to assess the pulse delay between vein and artery signals in order 
to estimate the retinal pulse wave velocity, as a measure of the vessel rigidity. Using this 
approach, it has been possible to correlate the vessel rigidity with glaucoma damage (6), 
vasospastic propensity (7) or blood pressure (8). The pulse delay assessment implies a Fourier 
signal decomposition whose first peak corresponds to the HBR. Furthermore, in (8), the 
authors considered the mean and scattering of the PA of each vessel and tested their 
correlations with other parameters. But to our knowledge, the HBR and PA have only been 
considered as two aggregate values for a whole signal. Here, our approach results in assessing 
their temporal evolution, allowing  to investigate whether their temporal variations are 
correlated or not. 
Section 2 is a presentation of the computer tool and of its algorithms, while section 3 is a 
description of some experimental results we obtained from a PA/HBR relationship 
investigation. 
2 Methods 
2.1 Subjects 
This study followed the principles of the Declaration of Helsinki and was approved by an 
Ethics Committee. Sixteen healthy subjects older than 18 years with at least 20/20 vision and 
a normal fundus were considered for the study. Each of them received full oral and written 
information and gave written consent prior to inclusion. Before RVA examination, 
participants were instructed to restrain from coffee, cigarette and alcohol consumption, as 
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well as from physical exercise for 12 hours. Then, routine ophthalmological examination was 
performed including a medical history, best-corrected visual acuity testing with manifest 
refraction, intraocular pressure (IOP) measure by applanation tonometry, slit lamp 
biomicroscopy and fundoscopy. Arteriovenous (AV) ratio was calculated using the built-in 
software of the RVA. For pupil dilation, topical tropicamide was applied on the examined 
eye. 
 
2.2 Signal acquisition 
Details on the RVA technology have been published earlier, by other authors ( (4), (5)). 
Schematically, it consists in the association of a classical fundus camera (FF450, Carl Zeiss 
GmbH, Germany) which records the fundus image through a videorecorder, and a built-in 
software which performs the image analysis. The illumination light of the fundus camera is 
reflected by the different layers of the retina and by the retinal vessels before reaching the 
camera (charge-coupled device). The basic principle relies on the specific optical properties of 
the hemoglobin within the retinal vessels, which absorbs light at a maximum wavelength of 
400-620 nm whereas the surrounding tissues mostly reflect it. Thus, when a green filter is 
inserted between the white light source and the retina, the images are very contrasted, with a 
high brightness difference between the hemoglobin and the surrounding tissues (figure 1).   
The build-in software of the RVA makes use of this contrast to locate the vascular vessels on 
the images. It allows the user to select vascular segments and then tracks these segments in 
the successive images (25 images per second) and assesses their diameters. The successive 
diameter measurements are then exported as Excel datasheets (Microsoft Corporation, 
Redmond, WA) for off-line analysis. 
Since the image scale of each eye is unknown, the diameter values are expressed in relative 
units (RU). If the examined eye has the dimensions of the normal Gullstrand eye, this unit 
corresponds to the micrometer. 
In our study, the selected vascular segments were an arterial and a venous segment, 
approximately 500 µm long and 100 µm large (figure 1), whose diameter temporal evolution 
has been recorded during one or two minutes for each subject. We focused on the spontaneous 
changes of HBR and PA and did not use external stimulation such as flicker light that has 
been suggested by other authors (5) and is made available by the RVA. 
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2.3 Signal decomposition 
An individual record contains two signals, corresponding to the two selected vessel segments. 
Figure 2 shows an example of observed record: both artery and vein signals clearly exhibit 
cardiac pulsations. The tool that we present analyses each record and divides it into a 
succession of pulsations, for which a duration (and hence a corresponding heart beat rate 
HBR) and a pulse amplitude PA for both vessels are estimated (figure 3). Thus, each 
individual record results in a sequence of cycle HBR, arterial PA and venous PA. 
A signal can be represented as a sequence of values (ti, yi) for the time and the corresponding 
vessel diameter. It has some missing and spurious data. The process leading to the signal 
division runs through three steps: first, the spurious data are identified and removed; second, 
the signal is decomposed into multi-resolution signals; and third, this decomposition is used to 
delimit the cardiac cycles.  
 
2.4 Artifact identification 
The first task is to detect and remove artifacts from the signal. Indeed, the RVA recorder 
generates spurious data, for example during loss of fixation by the patient. Furthermore, these 
artifacts are sometime grouped: their occurrence then results in a succession of outliers. 
The algorithm we developed to detect artifacts is based on a basic idea: around each signal 
data (ti, yi), we build a local model of the signal and estimate the local residual standard 
deviation σ, which characterizes the measurement noise. Then we compare the model residual 
at point ti to σ:  if it is significantly greater than σ, we decide that the observation (ti, yi) is 
spurious (figure 4). 
More precisely, for a data point (ti, yi), we build a local model to fit the training examples 
{(tj, yj) , j  J} of the set  
 RttrjJ ij  / , 
where r and R are predefined parameters. The constraint that |tj-ti|R ensures that the resulting 
model is local, while the constraint that |tj-ti|r ensures that the i'th point and its neighbors are 
unused in the model construction. Indeed, if the i'th point is an artifact, the neighbors are 
likely to be also artifacts and should therefore be excluded as well. The local model is a 
function f(t, θ) whose parameter vector θ is set to the least squares value θls, the one the 
minimizes the total squared error 
  


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In our program, the functional form is a two-phase linear function: 
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This model is piecewise linear in its parameters and the parameter vector θls is obtained from 
the ordinary least squares formula: we call y the column vector of the training example 
outputs y = (yj, jJ); we show in the appendix how to build an experience matrix x from the 
training inputs (tj, jJ) such that the model output to the training examples is xθ. Then the 
total squared error L(θ) is the quadratic norm ||y-xθ||2 of the residual vector and its minimum 
is found by setting its gradient with respect to θ to zero. When the matrix x is full rank, it 
results in: 
    yxxxθ t1tls

  (3) 
We can now define a confidence interval for Yi in order to decide whether the example (ti, yi) 
follows the same distribution as the examples {(tj, yj) , j  J} (see (9) and the illustration on 
figure 4). In order to distinguish this interval for a random variable Yi, from the classical 
confidence interval for a non random value such as a mathematical  expectation or a standard 
deviation, we call it a “prediction interval” (10). 
If the model contains the “real” regression function and if the noise of Y is Gaussian with a 
uniform variance σ², that is if there exists a parameter value θ0 and a normal random variable 
W with zero mean and unit variance such that 
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then the model value f(ti,θls) is a normal random variable whose expectation and variance are 
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Since Yi does not belong to the training set, it is independent from f(ti,θls) and their difference 
Yi - f(ti, θls) is normally distributed with a mean equal to the difference of the means and a 
variance equal to the sum of the variances. Therefore, the following random variable is 
normally distributed with zero mean and unit variance: 
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Furthermore, the estimator S² of the variance σ² is χ² distributed: 
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where n is the number of training examples (the size of J) and p the number of independent 
parameters of the model. Considering the independence of these two random variables, their 
ratio defines a Student variable with n-p degrees of freedom: 
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We can hence compute a 1-α prediction interval: 
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where tinvn-p is the inverse of the Student(n-p) cumulative distribution function. If the value yi 
of Yi lies in the interval, then the hypothesis that Yi has the distribution (4) is accepted. 
Conversely, if yi lies outside the prediction interval, the hypothesis is rejected with a risk of 
error α and the point (ti, yi) is considered as a spurious point.  
The local model and the artifact identification are applied iteratively: first, all the signal points 
are tested and, for each individual test, all neighboring points are used to build the local model 
and the prediction interval. Then the spurious points are removed, and the algorithm is 
reiterated: only the remaining points are tested and, for each individual test, only the 
remaining points around are used as training examples to build the local model and the 
prediction interval. The points that are identified as spurious are removed and the process is 
reiterated until there is no residual spurious point. 
All the points identified as artifacts are removed from the signal: the next steps of the analysis 
use signals without any of these points. 
 
2.5 Multiresolution signal decomposition 
The next step is to decompose the signals at the appropriate time scale. Indeed, the signal 
variations have other causes than heart beats, for example vasomotion or noise. In order to 
extract the cardiac pulsations, we use the signal dynamic properties and remove its variations 
that are too slow or too fast as compared to the HBR order of magnitude. We do this by using 
a multiresolution decomposition inspired by (11). The two timescales T1 and T2 are predefined 
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parameters such that T1>>T2, (3 and 0.1 sec. as default values) and the signal is decomposed 
into these two scales and a residual according to:  
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The decomposed form of the signal is (see figure 5) 
 
The first scale decomposition term d1(t) contains slow variations that can be seen at a time 
scale T1 (3 sec.) or more; those are long term movements that are not caused by cardiac beat. 
The second scale resolution signal d2(t) contains the variations which, being faster, cannot be 
seen at the time scale T1, but are still visible at the scale T2 (0.1 sec.). This is the case of the 
heart beat signal. At least, the residual r2(t) is a short term movement that cannot be seen 
neither at scale T1 nor T2. It is mainly made of noise. This decomposition enables to isolate 
the second decomposition scale d2(t), which is the part of the signal we use to delimit the 
cycles. 
 
2.6 Cardiac cycle delimitation and validation 
After the artifacts have been removed and the signal decomposed at the appropriate 
timescales, the cardiac cycles can be delimited and validated, on both vein and artery signals 
(figure 3). As can be seen on figures 2 and 3, the cycles are much more noticeable on the 
venous than on the arterial signal. For this reason, we first set the periods of the first signal, to 
which we synchronize the second signal division, with a flexible time advance. For the same 
reason, the HBR of the period is estimated with the venous period duration, while the arterial 
division is only used to estimate the arterial PA. 
The vein signal period delimitation is performed with the second scale decomposition term 
d2(t) (formula (12)). Two new parameters are defined, Tmin and Tmax, which are the minimum 
)()()()( 221 trtdtdty 
y1(t) 
y2(t) 
r1(t) 
r2(t) 
(11) 
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and maximum values for a cycle duration. To start with, the period ending points are set as the 
local minima of d2(t): they are the time points tlim such that 
  )()(,/ lim22minlim tdtdTttt   (12) 
and the periods are the intervals between two such successive points. Then the algorithm tries 
to concatenate these periods. Each one is grouped with the next one, and a “shape validation 
procedure” evaluates whether the enlarged period is likely to correspond to a cardiac cycle or 
not. If yes, the enlarged period is accepted and the intermediate delimitation point is removed.  
The arterial period synchronization implies another parameter, dtmax (0.32 sec. as default 
value), which is the maximal time delay of one signal on the other. For every vein period with 
ending point tlim, we define a corresponding arterial period whose ending point is the 
minimum of the arterial second scale decomposition term d2(t) on the interval [tlim- dtmax, tlim].  
The last step is the period validation. Each period is evaluated: first, its duration is compared 
with the parameters Tmin and Tmax; second, the “shape validation procedure” is run. The 
periods that are not validated as cardiac cycles remain in the signal division, but are not taken 
into account for further statistics: their invalidation is generally the consequence of a locally 
too noisy or too flat signal, and their HBR and PA assessment would not be trustworthy. 
The basic idea of the “shape validation procedure” is that a signal interval, when it 
corresponds to a cardiac cycle, consists more or less of an increasing phase followed by a 
decreasing one, with limited oscillations around this skeleton (figure 6). To implement it, the 
procedure models the second scale decomposition d2(t) as a two-phase linear regression (the 
model construction is described in the appendix), checks that the model has the expected 
variation signs and that its error is small enough as compared to the d2 standard deviation. The 
procedure also checks that the second scale residual r2(t) has small variations as compared to 
d2(t). 
Let P=[tbegin, tend] denote the evaluated period, f(t,θls) the two-phase linear model of the signal 
in the period and tc the model changeover point. Let  minP(y(t)), maxP(y(t)), meanP(y(t)), and 
stdP(y(t)) denote the extreme values, mean and standard deviation of signal y(tj) on the period 
P. The procedure validates the period if the following conditions are all fulfilled: 
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Condition C1 controls the data noise as compared to the pulse amplitude. Condition C2 
controls how close the two-phase linear model is to the second scale decomposition term d2(t) 
and condition C3 checks that the changeover point tc corresponds to a maximum.  The bounds 
noise_max and error_max are parameters of the algorithm whose default values are 35% and 
50%.One should notice that this procedure is invariant to homothetic transformation of the 
signal according to the time t and/or to the vessel width y. 
Once the periods are set and validated, their HBR and PA can be estimated: the HBR of 
period P is inverse to the venous period duration tend-tbegin, and the PA of each vessel is the 
amplitude maxP(y(t))-minP(y(t)) of the second scale decomposition term during the period. 
 
2.7 User defined modification 
The algorithm presented above is automatic. Once its parameters are set, it directly gives a 
structure to the RVA signal: it removes the spurious data, decomposes the remaining signal at 
the appropriate time scales, divides it into periods and selects the ones which are likely to 
correspond to cardiac cycles. The algorithm parameters are recalled in table 1. 
However, the user may disagree with some of the algorithm results and the program allows 
him to modify them manually. These corrections comprise changing the artifact status of any 
point, adding or deleting a period delimitation and forcing a cycle validation or invalidation. 
In particular, the artifact detection inevitably leads to false positives: if the test level is α, a 
proportion α of the non spurious points will be wrongly identified as spurious. Furthermore, 
the proportion of false negative is unknown but is non-zero and some spurious points may 
remain undetected. The manually modified result can then be saved into a file and reloaded in 
further sessions using the signal. 
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To limit the subjectivity induced by allowing to modify the algorithm result or not, we 
restricted ourselves to some artifacts undetected by the algorithm and to some period 
invalidation. The experimental results presented in the next section were obtained with only a 
few user defined modifications, and those respected the following rules: 
 We felt free to change the artifact status of any point. But once the artifact list had been 
set, we kept it constant, whatever the results of the signal decomposition, 
 The periods delimitations remained unmodified: no delimitation has been added, deleted 
nor shifted, 
 However, we permitted ourselves a few periods invalidation: when there was a significant 
change of duration of two successive cycles, both have been rejected if there was 
uncertainty about their delimitation.  
3 Experimental results 
The tool described above has been applied to the individual RVA records obtained for the 16 
subjects. The algorithm hence produced 16 series of validated pairs (HBR, PA) for both the 
arteries and the veins. The signal properties are not homogenous: the cyclic variations due to 
the heart beats are more easily identified for the veins than for the arteries, resulting in more 
validated periods (table 2).  
We used these divisions to investigate whether the PAs and HBR are related or not. Each of 
the 16 records has been studied statistically for both vessels. 
 
3.1 Individual modeling 
To start with, we built individual models: for each record we computed: 
‒ The linear correlations between the PAs and HBR,  
‒ A p-value testing the absence of correlation between the variables (Pearson’s test) against 
the alternative hypothesis of their negative correlation, 
‒ a linear regression of the PAs on HBR and an estimation of its standard error. 
The results are displayed on table 3 and the regressions are plotted on figure 7. For most 
subjects there was a negative correlation between PA and HBR for both arteries and veins, yet 
statistical significance (p≤0.05) was observed in only 1 subject. 
A point worth mentioning from figure 7 is the disparity of the HBR and PA domains, which 
differ significantly from an individual to another. This observation suggests that PA is not a 
simple function of HBR, but also depends on individual specificities. The model standard 
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errors are shown on figure 8. When computed on all the records together, they equal 1.01 RU 
for the arteries and 1.14 RU for the veins. Each individual regression has 2 parameters, hence 
the overall modeling (one model per record) has 32 independent parameters for each vessel 
type. 
 
3.2 Global modeling 
In building the individual models, a significant negative correlation between PA and HBR 
appeared only for one individual. A reason may have been the small number of validated 
periods per individual, as compared to the correlation order of magnitude. To overcome this, 
we have concatenated all the records and built two large datasets, one for the arteries and one 
for the veins. In both cases, we computed the linear correlations, tested the correlation, built 
2-degree regressions of PA on HBR and estimated their standard errors. Table 4 shows the 
results, figure 7 displays the two data sets and the corresponding second degree regressions 
and figure 8 shows the model standard errors. 
These results show a significant negative correlation between the HBR and PA. However, the 
polynomial regressions are not monotonic and their standard errors are much larger than those 
obtained with the individual models. This may be consistent with the number of independent 
parameters, which is now of only 3 instead of 32 for each vessel type, but this model 
reduction does not take the individual specificities into account. For example, it can be seen 
from figure 7 (middle right) that some vein data points have a low HBR and a high PA. But it 
can also be seen, from figure 7 (top right), that they may correspond to records whose PA is 
globally very high. It is therefore difficult to know whether these high observed values have 
to be attributed to low HBR values or to individual effect.  
 
3.3 Linear mixed effect modeling 
In order to include both the individual and the HBR effects in the modeling, we have built, for 
each vessel type, a linear mixed effect (LME) model (12). A LME model has a random effect, 
here the individual record, and a fixed effect, here the HBR. In our case, for a data point i of 
the record r, the model output is 
  irirrir HBRbaPA ,,,   (14) 
The coefficient ar is specific to the record r, it is the individual effect which is considered as 
random; the fixed effect b is common to all the records and the residuals εr,i are independent 
identically distributed random variables.  
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Fitting the models to the data, by using the “restricted maximum likelihood” method (12), 
resulted in the parameters of table 5. The model plots are shown on figure 7 and their standard 
errors on figure 8. 
The standard model errors are 1.03 RU for the arteries and 1.14 RU for the veins. They are 
significantly lower than the global model standard errors (1.72 RU and 2.53 RU), and nearly 
the same than the individual model standard errors (1.02 RU and 1.14 RU). The number of 
independent parameters lies between the two former modeling sizes: there is one common 
parameter b and a specific ar for each record, that is 17 parameters for each vessel type. They 
have to be compared with 32 parameters in the case of individual modeling, and with 3 
parameters in the global modeling. The LME modeling has less parameters than the 
individual modeling with the same performance, while the global modeling has less 
parameters than both LME and individual, but this gain is paid by an important loss of 
performance. The best modeling is clearly the LME. It is rich enough to take the individual 
disparities into account, and still allows a HBR term that is common to all. 
Both for the arteries and for the veins, the multiplicative coefficient b of the HBR term is 
negative. Furthermore, we evaluated its significance by testing the null hypothesis b=0 (i.e. 
zero correlation) against the alternative hypothesis b≠0. As shown in the last row of table 5, 
the p-value is 0.0006 for the arteries and 0.0002 for the veins: in both vessel types, the null 
hypothesis is clearly rejected and the coefficient b is significantly negative. 
4 Discussion 
We found a negative correlation between the heart beat rate and the pulse amplitude, in 
particular the venous one, i.e. the lower the HBR, the higher the pulse amplitude. The most 
important component of the variability of the HBR is the diastole, that it, the time during 
which the heart is at reast between two constrictions (the systoles). Hence, a lower heart beat 
rate means a longer diastole. During diastole, the venous diameter progressively decreases to 
reach a nadir immediately after the beginning of the systole. It is assumed indeed that the 
venous flow is continuous, and may even lead to a complete emptiness of the vein. The latter 
can indeed be observed around the optic disc. The depth of the nadir is therefore linked to the 
length of the diastole. Since the venous diameter during systole does not vary significantly, 
any change in length will modify the depth of the venous nadir and hence the pulse amplitude 
at the next systole. The fact that the vein may become completely empty during diastole 
indicates that venous flow does not depend only on the "pushing effect" of arteriolar flow, but 
that intraocular pressure probably also contributes to venous outflow. Future works on the 
  14 
relationship between PA and HBR could lead to algorithms that could provide an estimate of 
intraluminal venous pressure, an important parameter in cardiology. For instance, it is 
expected that an increased venous pressure would weaken the relationship between PA and 
HBR. This will require to improve the quality of data and in particular adress the issue of the 
frequent artifacts. 
5 Conclusion 
We have proposed a method for semi-automated analysis of the variations of retinal vessel 
diameters which decomposes the RVA signal into a succession of pulsations corresponding to 
cardiac cycles. It allows to display the temporal changes of the pulse amplitude and heart beat 
rate. Using this tool, we have shown that, for healthy patients, there is a significant negative 
correlation between these two variables. However, significant individual disparities suggest 
that the pulse amplitude also depends on other hemodynamic factors which remain to be 
identified. The construction of a model linking hemodynamic factors, intraocular pressure and 
vessel diameters, may allow inferring hemodynamic values such as intraluminal pressure 
and/or vessel compliance. This emphasizes the potential medical importance of our approach. 
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Appendix: construction of a two-phase linear regression model 
First of all we recall the least squares formula. Let y denote a N×1 vector, x a N×p matrix and 
θ a p×1 unknown vector. If p<N and if the rank of x is p, then the minimization in θ of the 
quadratic function 
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is obtained for the least squares value θls: 
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This solution is found by setting the gradient of (A1) with respect to θ to 0. 
 
Now, let (tj, yj), j=1,…,N be a set of training points such that 
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We look for the least squares parameter value θls which minimizes the quadratic loss function 
L(θ): 
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In this appendix, we show how to compute the least square parameter value θls. The basic idea 
is that, since the model f(t,θ) is piecewise linear in its parameter θ, the loss function L(θ) is 
piecewise quadratic with the form (A1). In particular, there is a parameter dimension p and a 
matrix x of size N×p such that θls is the minimum of the quadratic function (A1) and can be 
expressed by (A2).  
The changeover point tc is either in the set S
(0)
 = (-∞, tt]  [tN, +∞), or in a set S
(k)
 = [tk, tk+1]. 
We solve (A5) analytically on each set S
(k)
 and denote p
(k)
, 
)(k
lsθ , x
(k)
 and L
(k)
 the 
corresponding parameter dimension, least square parameter, experience matrix and loss 
function value. 
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i. Solution on S(0) 
If tc≤t1 or tc≥tN, then the model is linear on [t1, tN] (single-phase model): 
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The loss function is 
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where y is the vector of the (yj) and x
(0)
 is: 
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This loss function has the form (A1) and its minimum is hence given by (A2): 
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The optimal loss value L
(0)
 is deduced from (A7) with θ = 
)0(
lsθ  and the number p
(0)
 of 
independent parameters is 2. 
 
ii. Solution on S(k) with k ≠ 0 
If tk ≤ tc ≤ tk+1 , then the model is 
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The following constrained optimization has to be solved: 
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First, the minimization is solved without constraint, and we check whether the solution 
satisfies the constraints or not. If yes, it is the solution of (A11). If not, the optimization is 
performed after saturation of one constraint and the other (both cannot be saturated 
simultaneously), and the solution with the lowest loss value is selected. 
 Unconstrained problem 
The loss function takes the form (A1) with the experience matrix x
(k)
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Its solution is therefore obtained by applying (A2): 
    yxxxθ (k)t1(k)(k)t(k)ls
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If it fulfills the constraints, it is the solution of (A11). The number p
(k)
 of independant 
parameters is 4, the experience matrix is given by (A12) and the loss value by (A1). 
 Constraint saturation 
If the parameter value given by (A13) does not fulfill the constraints, the latter have to be 
saturated. Both cases tc = tk and tc = tk+1 are considered, and the solution with the lowest error 
is kept. Since both are solved in the same way, we now explicit only the first case. The 
constraint implies 
  )( 1212 bbtaa k   (A14) 
By injecting (A14) in (A10), we get 
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The loss function then takes the form (A1) with the experience matrix x
(k)
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and its solution is given by (A2): 
    yxxxθ (k)t1(k)(k)t(k)ls

  (A17) 
This parameter vector, completed by the a2 value from (A14), gives the solution of (A11) with 
the first constraint saturated. The number p
(k)
 of independant parameters is 3, the loss value 
L
(k)
 is deduced from (A1) with the experience of (A16). The same procedure is used to solve 
(A11) with the second constraint saturated, and the best of the two is the solution of (A11). 
Note that the solution of (A11) on S
(k)
 under the second constraint saturation may be used to 
solve (A11) on S
(k+1)
 under the first constraint saturation.  
 
iii. Global solution 
The global solution of (A5) is merely obtained by considering all the solutions 
)(k
lsθ  on the 
subsets S
(k)
 (k=0,…,N-1), and by selecting the one with the lowest loss value L(k). The 
parameter dimension p and experience matrix x are the corresponding p
(k)
 and x
(k)
. 
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 Parameter Description Default value 
Spurious point 
detection 
r and R 
Temporal radius for training 
examples selection 
0.10 and 0.40 sec. 
α Statistical test level 2% 
Multiresolution 
decomposition 
T1 and T2 Long and short term timescale 3.0 and 0.1 sec. 
Period delimitation 
Tmin and Tmax Extrema of cycle duration 
0.5 and 1.71 sec. 
(correspond to 
HBR extrema of 35 
and 120 bpm) 
dtmax 
Maximum time delay between 
arterie and vein 
0.32 sec. 
Period shape 
validation 
noise_max Maximum noise/PA ratio 35% 
error_max 
Maximum model error/std 
ratio 
50% 
 
Table 1: synthetic view of the algorithm parameters.  
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Record 
Artery Vein 
Periods 
Validated 
periods 
Mean HBR SD HBR Periods 
Validated 
periods 
Mean HBR std HBR 
1   116   99   72.5   7.0   102   101   72.2   7.5  
2   118   25   77.5   13.5   124   62   72.7   12.6  
3   91   31   80.2   12.6   90   43   78.0   14.2  
4   124   97   65.0   6.6   115   98   65.8   6.8  
5   112   29   60.6   6.7   108   104   60.3   5.7  
6   133   26   84.8   12.5   134   53   84.9   12.0  
7   42   5   54.4   2.3   42   42   53.6   3.8  
8   63   19   87.2   11.5   60   36   87.7   11.0  
9   55   28   72.7   8.6   55   44   73.6   10.0  
10   49   13   71.0   9.8   53   51   69.4   6.8  
11   44   18   62.7   5.4   43   43   62.2   5.9  
12   68   5   90.6   4.7   66   60   90.6   7.3  
13   78   35   86.1   5.7   75   72   86.0   5.8  
14   51   24   62.4   4.8   47   47   62.8   4.7  
15   108   14   102.1   10.9   106   101   99.2   9.0  
16   36   14   56.3   13.5   40   30   55.1   11.0  
Table 2: synthetic view of the 16 records (Mean HBR and SD HBR in beats per minute). 
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Record 
Artery Vein 
Validated 
periods 
Corr 
HBR/PA 
p 
Model std 
error 
Validated 
periods 
Corr 
HBR/PA 
p 
Model std 
error 
1 99 -0.35 <0.01 0.81 101 -0.23 0.02 0.78 
2 25 -0.32 0.12 1.09 62 -0.12 0.37 1.04 
3 31 -0.02 0.92 0.63 43 -0.09 0.57 1.11 
4 97 -0.07 0.47 0.64 98 -0.04 0.68 0.69 
5 29 -0.35 0.06 0.83 104 -0.00 0.99 0.79 
6 26 0.15 0.45 0.79 53 -0.05 0.72 1.24 
7 5 0.20 0.75 0.50 42 -0.15 0.35 0.87 
8 19 0.04 0.88 1.78 36 -0.17 0.33 1.41 
9 28 -0.07 0.71 1.44 44 -0.08 0.59 1.12 
10 13 -0.18 0.55 1.45 51 -0.11 0.46 1.90 
11 18 -0.41 0.09 0.64 43 -0.24 0.13 1.00 
12 5 -0.21 0.74 0.34 60 -0.12 0.37 1.36 
13 35 -0.28 0.10 0.60 72 -0.15 0.21 0.57 
14 24 -0.01 0.96 1.21 47 -0.23 0.12 1.14 
15 14 0.09 0.75 1.92 101 -0.14 0.15 1.15 
16 14 -0.47 0.09 2.29 30 -0.17 0.36 2.64 
Table 3: correlations between HBR and PA, p-values of the independence test and standard 
error (in RU) of the individual linear regressions. 
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 Arteries Veins 
Regression formula 
PA = 4.26 - 0.03 (HBR-72.76) + 
0.0013 (HBR-72.76)
2
 
PA = 4.85 - 0.07 (HBR-74.45) + 
0.0023 (HBR-74.45)
2 
Regression standard 
error 
1.72 2.53 
Correlation -0.09 -0.31 
p 0.04 <0.0001 
 
Table 4: results for the global modeling (HBR in beats per minute, PA and regression error in 
RU). 
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Record 
Arteries Veins 
Model formula 
(PA:RU, HBR: bpm) 
Standard 
error (RU) 
Model formula 
(PA:RU, HBR: bpm) 
Standard 
error (RU) 
1 PA = 6.32 -0.019 HBR 0.82 PA = 5.12 -0.016 HBR 0.79 
2 PA = 5.99 -0.019 HBR 1.09 PA = 4.57 -0.016 HBR 1.05 
3 PA = 4.75 -0.019 HBR 0.67 PA = 5.32 -0.016 HBR 1.12 
4 PA = 4.58 -0.019 HBR 0.64 PA = 4.05 -0.016 HBR 0.69 
5 PA = 5.00 -0.019 HBR 0.85 PA = 5.68 -0.016 HBR 0.80 
6 PA = 4.68 -0.019 HBR 0.87 PA = 5.91 -0.016 HBR 1.25 
7 PA = 3.80 -0.019 HBR 0.55 PA = 11.62 -0.016 HBR 0.87 
8 PA = 6.88 -0.019 HBR 1.80 PA = 6.61 -0.016 HBR 1.41 
9 PA = 7.67 -0.019 HBR 1.44 PA = 6.93 -0.016 HBR 1.12 
10 PA = 8.17 -0.019 HBR 1.45 PA = 12.51 -0.016 HBR 1.90 
11 PA = 4.83 -0.019 HBR 0.66 PA = 7.86 -0.016 HBR 1.01 
12 PA = 3.70 -0.019 HBR 0.39 PA = 7.07 -0.016 HBR 1.36 
13 PA = 4.74 -0.019 HBR 0.60 PA = 4.28 -0.016 HBR 0.57 
14 PA = 8.25 -0.019 HBR 1.21 PA = 9.82 -0.016 HBR 1.16 
15 PA = 8.99 -0.019 HBR 1.96 PA = 6.46 -0.016 HBR 1.15 
16 PA = 8.83 -0.019 HBR 2.49 PA = 11.21 -0.016 HBR 2.65 
All PA = ar -0.019 HBR 1.03 PA = ar -0.016 HBR 1.14 
p-
value(b=0) 
0.0006 0.0002 
 
Table 5: the LME models and their performances. For each vessel type, the additive 
coefficients are specific to each record and only the coefficient b of the HBR term is common 
to all records. The last row is the result of testing the hypothesis b=0. 
 
  
  25 
 
 
Figures 
 
 
 
 
 
 
Figure 1: eye fundus image showing an example of two selected vascular segments whose 
diameters are measured by the RVA. 
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Figure 2: an example of RVA record, with a venous and an arterial signal. Spurious points 
(▲) are removed and a baseline (bold black line) is calculated. The heart beat pulsations 
appear clearly around the baseline. 
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Figure 3: the RVA signal is decomposed into a succession of periods. Some of them, like the 
central one, in the bold rectangle, are likely to be cardiac cycles; a duration is estimated on the 
vein signal, and two pulse amplitudes are then estimated, one for the artery and one for the 
vein. Other periods may be rejected, for one or both vessels, because of the lack of regularity 
of the signal (grey rectangles). This decomposition requires first to identify spurious (▲) and 
correct (×) data, second to compute a multi-resolution decomposition (plain lines) of the 
signal, and third to delimit and validate the cardiac cycles. 
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Figure 4: illustration of spurious points identification. The tested point is shown by the arrow 
(t=99.40 sec, y=163.19 RU). The data points whose distance to this point is between 0.1 and 
0.4 sec. are used as training examples to build a local model (a two-phase linear regression). 
From the dispersion of these training examples around the local model, the procedure 
estimates the local noise  and infers a 2% prediction interval for the tested point. Here, the 
tested point is outside the prediction interval and is hence identified as spurious. 
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Figure 5: the signal is decomposed into a long term resolution signal y1(t) (T1 = 3 sec, in bold 
line), a mid term resolution signal y2(t) (T2 = 0.1 sec, in thin line) and the original signal y(t) 
(in ×). 
 
 
 
Figure 6: illustration of the «shape validation procedure». The evaluated intervals are the left 
and central arterial periods of the figure 3. A two-phase linear regression model is built to 
approximate the second scale decomposition term d2(t). In the first example (left), the model 
error, as compared to the d2(t) standard deviation, is too important (ratio of 0.53>0.50) and the 
interval is not validated. The second interval (right), fulfilling all the conditions, is validated. 
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Figure 7: the individual linear regressions (top), global 2-degree regressions (middle) and 
linear mixed models (down) for the arteries (left) and the veins (right). The global models are 
shown with the data sets and a 0.95 prediction interval. 
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Figure 8: standard errors of the 3 modeling approaches for the arteries (left) and veins (right). 
The standard errors are displayed record by record and then for all records together. 
 
